Skip to main content

Market Overview

Benzinga's Weekend M&A Chatter


The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 3 through Sunday June 5, 2016:

Twitter, Yahoo Said to have Discussed Potential Merger

The Rumor:
Twitter (NYSE: TWTR) met with Yahoo (NASDAQ: YHOO) management, including CEO Marissa Mayer, to discuss a potential merger, according to sources as reported by the NY Post on Friday. The meeting is said to have taken place several weeks ago, but Twitter decided to not to proceed with the bidding process.

Yahoo and Twitter declined comment.

Verizon (NYSE: VZ) is still seen as the front runner to acquire Yahoo's core internet business, with AT&T (NYSE: T) and Dan Gilber also potential buyers.

Yahoo fell 15% Friday to close at $36.60.

McKesson Considering Separation of IT Unit

The Rumor:
McKesson Corp. (NYSE: MCK) is considering separation its information-technology business, according to sources as reported by the Wall Street Journal late Thursday. The unit is said to be valued at more than $5 billion.

McKesson closed at $186.46 on Friday, down $1.33.

AstraZeneca, Teva, Biogen, Allergan Said to be Potential Bidders for Acadia

The Rumor:
AstraZeneca (NYSE: AZN) is said to be among potential bidders for Acadia Pharmaceuticals, according to a report from the UK Daily Mail late Friday. Sources say Acadia investors would not accept less than $60 per share.

Other potential buyers include Teva Pharmaceutical Industries (NASDAQ: TEVA), Biogen (NASDAQ: BIIB) and Allergan (NYSE: AGN), the report said.

Acadia closed at $36.07 on Friday and traded up 3.5% after-hours.

Bayer Chairman Said to have Held Secret Meeting With Investors Regarding Monsanto Bid

The Rumor:
Monsanto (NYSE: MON) shares spiked higher Friday, on a tweet from Fox Business' Charlie Gasparino indicating that the Bayer (OTC: BAYRY) Chariman Werner Baumann held a secret meeting on Thursday, to discuss the bid to acquire the U.S. agricultural company. Sources who attended the meeting said Baumann is willing to increase the offer for Monsanto.

Bayer offered $122 per share for Monanto last month, but shares have remained around $111 due in part to regulatory concerns and pressure from Bayer shareholders, who have been less than enthusiastic regarding the bid.

Monsanto closed at $111.00 on Friday, up $0.64.


Related Articles (AGN + AZN)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at